Sylatron
| Covered Uses: | All FDA approved indications not otherwise excluded from Part D. |
| Exclusion Criteria: | |
| Required Medical Information: | Adjunctive treatment of Stage III resected melanoma |
| Age Restrictions: | |
| Prescriber Restrictions: | |
| Coverage Duration: | 12 months |
| Other Criteria: |
Last Modified on 12/20/2012